Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mario Fontes-Sousa"'
Autor:
Daniela Dias, Tania Matos, Mario Fontes-Sousa, Catarina Silvestre, Filipa Serra, Ines Sapinho
Publikováno v:
Endocrine Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6afce0f6c17b97eaf9958a2ed51aabcb
https://doi.org/10.1530/endoabs.90.p746
https://doi.org/10.1530/endoabs.90.p746
Autor:
Mario Fontes-Sousa, Helena Magalhães, Ricardo Leão, André Mansinho, Mariana Malheiro, Alina Rosinha, Margarida Carrolo, Paula Borralho, Joaquina Mauricio, Margarida Brito, Jose Luis C. Passos-Coelho, Antonio Quintela
Publikováno v:
Journal of Clinical Oncology. 41:TPS435-TPS435
TPS435 Background: Testicular germ cell tumors (TGCT) are the most common solid malignancy in men aged 15 to 35, and Seminoma histology can account for up to half of the cases. Since the latest edition of the American Joint Committee on Cancer (AJCC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f7d527bd9651295dd53f5a6f5e97c5c
https://doi.org/10.1200/jco.2023.41.6_suppl.tps435
https://doi.org/10.1200/jco.2023.41.6_suppl.tps435
Autor:
Ana Filipa Reis, Thomas A Odeny, Diana Simão, Mario Fontes-Sousa, Ysel Chiara Vina Rodrigues, Channing Judith Paller, Pedro C. Barata
Publikováno v:
Journal of Clinical Oncology. 40:353-353
353 Background: ICI were approved for advanced RCC treatment either alone or combined with another ICI or a tyrosine kinase inhibitor. While most trial data derive from clear cell (cc) histology, the differential activity of ICI in nccRCC subtypes is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::513ef8ed686a22d812a5b9a4740c6eb2
https://doi.org/10.1200/jco.2022.40.6_suppl.353
https://doi.org/10.1200/jco.2022.40.6_suppl.353
Autor:
Thomas Powles, Alexandra Drakaki, Jeremy Yuen-Chun Teoh, Enrique Grande, Mario Fontes-Sousa, Camillo Porta, Esther Wu, Erik T. Goluboff, Svetlana Ho, Stephan Hois, Ashok Kumar Gupta, James W.F. Catto
Publikováno v:
Journal of Clinical Oncology. 40:TPS579-TPS579
TPS579 Background: The standard management of MIBC involves neoadjuvant cisplatin-based chemotherapy followed by radical cystectomy and pelvic lymph node dissection. Approximately 40% of patients with MIBC are cisplatin ineligible, the standard of ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90cbe5353fefc1722966c3911d53137a
https://doi.org/10.1200/jco.2022.40.6_suppl.tps579
https://doi.org/10.1200/jco.2022.40.6_suppl.tps579
Autor:
Guilherme Vilhais, Diogo Alpuim Costa, Mário Fontes-Sousa, Pedro Casal Ribeiro, Filipa Martinho, Carolina Botelho de Sousa, Catarina Rodrigues Santos, Ida Negreiros, Ana Canastra, Paula Borralho, Ana Guia Pereira, Cristina Marçal, José Germano Sousa, Renata Chaleira, Júlio César Rocha, Conceição Calhau, Ana Faria
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Locally advanced breast cancer poses significant challenges to the multidisciplinary team, in particular with hormone receptor (HR) positive, HER2-negative tumors that classically yield lower pathological complete responses with chemotherapy. The inc
Externí odkaz:
https://doaj.org/article/9d7afcb5d6a34ef7af322d501c24cad2
Autor:
Mário Fontes-Sousa, João Lobo, Helena Magalhães, João Cassis, Mariana Malheiro, Sância Ramos, Rui Henrique, Ana Martins, Maria Joaquina Maurício
Publikováno v:
BMC Urology, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Seminoma accounts for 30–50% of testicular germ cell tumors (TGCT)—the most common solid malignancy in men aged 15–35 years. The American Joint Committee on Cancer (AJCC) 8th edition (2018) created the subclassifications pT1
Externí odkaz:
https://doaj.org/article/ad3eda7db464462b888508a1495983eb
Autor:
Mário Fontes-Sousa, João Lobo, Silvana Lobo, Sofia Salta, Maria Amorim, Paula Lopes, Luís Antunes, Susana Palma de Sousa, Rui Henrique, Carmen Jerónimo
Publikováno v:
Molecular Medicine, Vol 26, Iss 1, Pp 1-9 (2020)
Abstract Background Breast cancer (BC) is a major health concern and better understanding of its biology might improve treatment decisions and patient outcomes. Histone3 Lysine27 tri-methylation (H3K27me3) is a post-translational histone modification
Externí odkaz:
https://doaj.org/article/eb77fa7d45344c0b90a772a606ed42c3
Autor:
Maria Amorim, João Lobo, Mário Fontes-Sousa, Helena Estevão-Pereira, Sofia Salta, Paula Lopes, Nuno Coimbra, Luís Antunes, Susana Palma de Sousa, Rui Henrique, Carmen Jerónimo
Publikováno v:
Frontiers in Genetics, Vol 10 (2019)
Breast cancer (BrC) is the most frequent malignancy and the leading cause of cancer death among women worldwide. Approximately 70% of BrC are classified as luminal-like subtype, expressing the estrogen receptor. One of the most common and effective a
Externí odkaz:
https://doaj.org/article/7cc5d043be5142d1bcf7ce8b6296e600
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018)
Gastric cancer (GC) remains a public health problem, being the fifth most common cancer worldwide. In the western countries, the majority of patients present with advanced disease. Additionally, 65 to 75% of patients treated with curative intent will
Externí odkaz:
https://doaj.org/article/15e9fd8920604bd385c134f612ab612d